Canada ‘lost headstart’ in cannabis market: Canadian Bioceutical CEO

Scott Boyes, CEO of Canadian Bioceutical, joins BNN to talk about delisting from the TSX Venture exchange in favour of the Canadian Securities Exchange. Restrictions on the venture prevented the company from accessing the U.S. market and so they chose to delist. Boyes says growth in the U.S. has surpassed Canada.

Related Posts

Leave A Reply